The median time to onset of ADEs is 23 days, with an interquartile range [IQR] of 790 days
Standard dosing begins at 0.25 mg weekly, increasing to 0.5 mg, then 1.0 mg, and potentially up to 2.4 mg weekly, depending on individual response and tolerance
UnitedHealthcare's pharmacy and therapeutics committee reviews formulary placement annually, weighing clinical outcomes data from trials like SUSTAIN-7 against cost-effectiveness benchmarks [3]
Thousand Oaks: Sage Publications, Inc
Ocular Migraines: Potentially triggered by stress, hormonal changes, or medications affecting blood vessels, though the exact cause is unclear
Dans le tableau 2 , les diffrentes formulations de lipase existant dans le monde industriel et leur origine sont rsumes